|
|
|
|
|
Product Name
|
MMP12 peptide (Carboxyterminal end)
|
|
Product type
|
Proteins and Peptides
|
|
Peptide
|
Synthetic peptide MMP12.
This peptide was used as an immunogen for ab38910 - MMP12 antibody - Carboxyterminal end.
|
|
Specificity
|
We have a range of domain specific antibodies for this target. For a full list please see all MMP12 antibodies
|
|
Tested applications
(see key)
|
ELISA, WB
|
|
Application notes
(see key)
|
Recommended dilutions ELISA: Use at an assay dependent dilution. WB: Use at an assay dependent dilution. This peptide can be used with studies using ab38910. Dilution optimised using Chromogenic detection. Not yet tested in other applications. Optimal dilutions/concentrations should be determined by the end user.
|
|
Research areas
|
Cardiovascular >> Atherosclerosis >> Thrombosis >> Other Cancer >> Tumor biomarkers >> Enzymes >> MMPs Cancer >> Invasion/microenvironment >> Angiogenesis >> ECM enzymes >> MMPs Signal Transduction >> Cytoskeleton / ECM >> Extracellular Matrix >> ECM Enzymes >> MMP Cardiovascular >> Angiogenesis >> Adhesion / ECM >> Matrix Metalloproteinases >> MMP
|
|
Relevance
|
Proteins of the matrix metalloproteinase (MMP) family are involved in the breakdown of extracellular matrix in normal physiological processes, such as embryonic development, reproduction, and tissue remodeling, as well as in disease processes, such as arthritis, metastasis, and atherosclerosis. Most MMP's are secreted as inactive proproteins which are activated when cleaved by extracellular proteinases.
MMP12 was first described in murine macrophages, later in human macrophages, and more recently in other cell types. Also known as metalloelastase, MMP12 is able to degrade elastin, entactin, laminin 1, fibronectin, type IV collagen as well as insulin B-chain and casein. MMP12 is often confused with the Serine proteinase, Leukocyte elastase (EC 3.4.21.37) because of similar nomenclature. MMP12 is structurally similar to the classical MMPs (MMP1, MMP3); it contains a propeptide with autoinhibitory cysteine switch site, a well-conserved zinc site, hinge region and hemopexin domain. MMP12 lacks a transmembrane domain and furin cleavage site. The zymogen for MMP-12 is about 54 kD, and is quickly activated to the 45 kD form; and this breaks down to cascade of active forms, ending with the common 22 kD form. Stimulated macrophages produce MMP12; it has also been found in osteosarcoma cells, synovial fibroblasts and lung fibroblasts.
|
|
|
|
|
Purity
|
>95% by SDS-PAGE
|
|
Storage buffer
|
Preservative: None Constituents: 0.001% Tween 20, 30mM HEPES, 2mM EDTA, 150mM Sodium chloride, pH 6.75
|
|
Form
|
Liquid
|
|
Concentration
|
1.000 mg/ml
|
|
Storage instructions
|
Shipped at 4°C. Upon delivery aliquot and store at -20°C or -80°C. Avoid repeated freeze / thaw cycles.
|
| |
At Abcam, we have one centralized database to hold all of our product information, so that everything we know about this MMP12 peptide (Carboxyterminal end) is on this datasheet. But please do contact us if you would like any reassurance! |
 |
|
| |
|
Search PubMed (MEDLINE) for references to MMP12
|
| |
MMP12 peptide (Carboxyterminal end) - more information
|
Customer reviews (feedback) regarding MMP12 peptide (Carboxyterminal end) |
Customer FAQs regarding MMP12 peptide (Carboxyterminal end) |
Protocols for MMP12 peptide (Carboxyterminal end) |
Price and availability of products related to MMP12 peptide (Carboxyterminal end) |
| |
MMP12 peptide (Carboxyterminal end) - related products:
|
|
|
| |
MMP12 peptide (Carboxyterminal end) - other tools:
|
Contact Abcam with a Technical Enquiry about MMP12 peptide (Carboxyterminal end) |
| |
All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"